SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-008187
Filing Date
2014-02-06
Accepted
2014-02-06 20:38:28
Documents
2
Period of Report
2014-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2992
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4585
  Complete submission text file 0001209191-14-008187.txt   9225
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Issuer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address OFFICE OF BUSINESS ADMIN & COORDINATION 303 BOJEON-DONG, GIGEUNG-GU YONGIN M5 446-770
Business Address OFFICE OF BUSINESS ADMIN & COORDINATION 303 BOJEON-DONG, GIGEUNG-GU YONGIN M5 446-770 82-31-260-9300
Green Cross Corp. (Reporting) CIK: 0001598477 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35443 | Film No.: 14581612